These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2876923)

  • 1. Tulobuterol in childhood asthma: single dose ranging and repeated oral dose comparative studies.
    Javier MA; Noche ML
    J Int Med Res; 1986; 14(5):228-35. PubMed ID: 2876923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of transdermal tulobuterol in pediatric asthma patients on long-term leukotriene receptor antagonist therapy: results of a randomized, open-label, multicenter clinical trial in Japanese children aged 4-12 years.
    Katsunuma T; Fujisawa T; Nagao M; Akasawa A; Nomura I; Yamaoka A; Kondo H; Masuda K; Yamaguchi K; Terada A; Ikeda M; Nishioka K; Adachi Y; Kurihara K
    Allergol Int; 2013 Mar; 62(1):37-43. PubMed ID: 23000726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged treatment with oral and inhaled tulobuterol does not induce airways tachyphlaxis.
    Patel KR
    Lung; 1990; 168 Suppl():210-8. PubMed ID: 1974679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of patch formulation of tulobuterol, a long-acting beta2-adrenoreceptor agonist, in the treatment of severe pediatric asthma.
    Yoshihara S; Yamada Y; Abe T; Arisaka O
    Ann Allergy Asthma Immunol; 2006 Jun; 96(6):879-80. PubMed ID: 16802779
    [No Abstract]   [Full Text] [Related]  

  • 5. [Efficacy and safety of tulobuterol patch versus oral salbutamol sulfate in children with mild or moderate acute attack of bronchial asthma: a comparative study].
    Lin Q; Liu QH; Bao YX
    Zhongguo Dang Dai Er Ke Za Zhi; 2013 Jun; 15(6):462-5. PubMed ID: 23791063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can a new beta 2-agonist reduce the mortality of asthma?
    Aldons PM
    Lung; 1990; 168 Suppl():186-91. PubMed ID: 1974675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical evaluation of tulobuterol patch in patients with mild or moderate persistent bronchial asthma-effects of long-term treatment on airway inflammation and hypersensitivity].
    Horiguchi T; Kondo R; Miyazaki J; Torigoe H; Tachikawa S
    Nihon Kokyuki Gakkai Zasshi; 2004 Feb; 42(2):132-7. PubMed ID: 15007912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of sustained-release tulobuterol on asthma control and beta-adrenoceptor function.
    Kume H; Kondo M; Ito Y; Suzuki R; Yamaki K; Takagi K
    Clin Exp Pharmacol Physiol; 2002 Dec; 29(12):1076-83. PubMed ID: 12390295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical evaluation of a transdermal therapeutic system of the beta2-agonist tulobuterol in patients with mild or moderate persistent bronchial asthma.
    Horiguchi T; Kondo R; Miyazaki J; Fukumokto K; Torigoe H
    Arzneimittelforschung; 2004; 54(5):280-5. PubMed ID: 15212190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the tulobuterol patch on the treatment of acute asthma exacerbations in young children.
    Katsunuma T; Ohya Y; Fujisawa T; Akashi K; Imamura N; Ebisawa M; Daikoku K; Kondo N; Terada A; Doi S; Nishimuta T; Noma T; Hamasaki Y; Kurihara K; Masuda K; Yamada T; Yamada M; Yoshihara S; Watanabe K; Watanabe T; Kitabayashi T; Morikawa A; Nishima S;
    Allergy Asthma Proc; 2012; 33(3):e28-34. PubMed ID: 22737706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pulmonary function tests in asthmatic children in treatment with tulobuterol].
    Pérez-Martini L; Blanco RA; Heffner G; Ordóñez-Comparini R
    Bol Med Hosp Infant Mex; 1989 Apr; 46(4):241-5. PubMed ID: 2719810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Long-acting beta 2-stimulants].
    Tamura G
    Nihon Rinsho; 2001 Oct; 59(10):1973-8. PubMed ID: 11676141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transdermal tulobuterol patch, a long-actingβ(2)-agonist.
    Tamura G; Ichinose M; Fukuchi Y; Miyamoto T
    Allergol Int; 2012 Jun; 61(2):219-29. PubMed ID: 22270072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of asthma with tulobuterol or albuterol in school-age children.
    Le Bourgeois M; de Blic J; Chauvin JP; Scheinmann P; Paupe J
    Clin Ther; 1990; 12(6):513-9. PubMed ID: 2289220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Open cross-over comparison of tulobuterol and fenoterol in asthmatic adult patients.
    Sanchez J; Rivero A; Dal-Re R; Azanza JR
    Int J Clin Pharmacol Res; 1988; 8(4):279-85. PubMed ID: 3182119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical-pharmacokinetic aspects of prolonged effect duration as illustrated by beta2-agonists.
    Rosenburg J
    Eur J Clin Pharmacol; 2002 Jul; 58(4):S1-21. PubMed ID: 12214578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical evaluation of tulobuterol aerosol in childhood asthma.
    Sienra-Monge JJ; Graham-Zapata LF; Del Rio-Navarro BE
    J Int Med Res; 1990; 18(6):483-8. PubMed ID: 2292330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of a combined treatment theophylline and tulobuterol on nocturnal chronic asthma.
    Rühle KH; Dorow P; Schmitz-Schumann H
    Lung; 1990; 168 Suppl():192-3. PubMed ID: 1974676
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of a patch formulation of tulobuterol on cough scores and PEF in patients with cough variant asthma].
    Fujimori K; Suzuki E; Gejyo F
    Arerugi; 2000 Aug; 49(8):658-61. PubMed ID: 11021018
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of the effects of tulobuterol patch and salmeterol in moderate to severe asthma.
    Nishiyama O; Taniguchi H; Kondoh Y; Kimura T; Kato K; Kume H; Shimokata K
    Clin Exp Pharmacol Physiol; 2006 Nov; 33(11):1016-21. PubMed ID: 17042908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.